Skip to content
healthcare.dev

GAVILAX

NDC 43386-312, Polyethylene Glycol 3350, powder, for solution, from Lupin Pharmaceuticals,Inc..

Product NDC
43386-312
Status
Listed
Labeler
Lupin Pharmaceuticals,Inc.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091077
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43386-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
43386-312-0843386031208238 g in 1 BOTTLE (43386-312-08)
43386-312-1443386031214510 g in 1 BOTTLE (43386-312-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 43386031208

    GET /v1/drugs/nadac/43386031208
  • NADAC price for package 43386031214

    GET /v1/drugs/nadac/43386031214

Use it

Look up 43386-312 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43386-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43386-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.